Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
about
Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.Atomic description of the immune complex involved in heparin-induced thrombocytopeniaHeparin-induced thrombocytopenia: pathogenesis and management.Pharmacotherapy of heparin- induced thrombocytopenia.PF4/heparin complexes are T cell-dependent antigens.Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparinDeterminants of PF4/heparin immunogenicityOptimization of a murine immunization model for study of PF4/heparin antibodies.Heparin-induced thrombocytopenia: present and future.Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Dynamic antibody-binding properties in the pathogenesis of HIT.Heparin induced thrombocytopenia: review.Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.Activated platelet-derived and leukocyte-derived circulating microparticles and the risk of thrombosis in heparin-induced thrombocytopenia: A role for pf4-bearing microparticles?5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
P2860
Q30483035-8F7C5BDC-6B50-42B0-A4C1-CF3DFDC77191Q30665349-1D80C21D-25AB-460C-91F8-31BE1422A203Q33348049-85D969D1-7876-4A76-96E8-1BCC8E5185F8Q33348283-CE6C5942-737A-455E-A32C-768F5E5EB09FQ33365918-52520BD8-F15A-47D8-A6BC-8BB4BD923B51Q33367978-3B8364D0-7497-4CB8-A8EA-0BD5D347B4AFQ33376629-61B200CE-93EA-48A9-A5B8-D453BEE0D3D0Q33383456-C475496C-F57A-4191-BFA7-F41771DD7103Q33394188-A10ABF5D-8AE5-443A-A357-43BD27E90CA9Q33399137-1F40FA24-BF75-46CC-96DD-EBD73DED8E2FQ33400120-5BF83352-DB37-4287-A8A0-74477B604A27Q33401163-05F1272C-3714-4B3C-9D84-300E81DD8FB9Q33410083-07758F50-99ED-44A2-9F3D-D9C095F8AABBQ33416269-630B6243-8F26-4D7F-A971-65D865097C64Q33418371-CCDD7ED5-1C0B-4058-A68D-A2C25BC66C62Q33438155-B0BF871D-A41D-4036-8727-8A729A664909Q52552212-195DCA61-A4A9-4075-AE2A-E0C62ED3F319
P2860
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Defining a second epitope for ...... HIT-like monoclonal antibody.
@ast
Defining a second epitope for ...... HIT-like monoclonal antibody.
@en
type
label
Defining a second epitope for ...... HIT-like monoclonal antibody.
@ast
Defining a second epitope for ...... HIT-like monoclonal antibody.
@en
prefLabel
Defining a second epitope for ...... HIT-like monoclonal antibody.
@ast
Defining a second epitope for ...... HIT-like monoclonal antibody.
@en
P2093
P921
P356
P1433
P1476
Defining a second epitope for ...... HIT-like monoclonal antibody.
@en
P2093
Brue S Sachais
Douglas B Cines
Gowthani M Arepally
Kwang S Park
Mortimer Poncz
Zhong Q Li
P304
P356
10.1182/BLOOD.V99.4.1230
P407
P577
2002-02-01T00:00:00Z